Convalescent plasma for COVID-19. A randomized clinical trial

…, GR van Pottelberge, IN Vlasveld, HSM Ammerlaan… - MEDRxiv, 2020 - medrxiv.org
Structured abstract for full paper Background After recovery from COVID-19, most patients
have anti-SARS-CoV-2 neutralizing antibodies. Their convalescent plasma could be an …

Eradication of Methicillin-Resistant Staphylococcus aureus Carriage: A Systematic Review

HSM Ammerlaan, JAJW Kluytmans… - Clinical Infectious …, 2009 - academic.oup.com
A systematic review was performed to determine the effectiveness of different approaches
for eradicating methicillin-resistant Staphylococcus aureus carriage. Twenty-three clinical …

[HTML][HTML] Effects of potent neutralizing antibodies from convalescent plasma in patients hospitalized for severe SARS-CoV-2 infection

…, IN Vlasveld, HSM Ammerlaan… - Nature …, 2021 - nature.com
In a randomized clinical trial of 86 hospitalized COVID-19 patients comparing standard care
to treatment with 300mL convalescent plasma containing high titers of neutralizing SARS-…

Effects of confounders and intermediates on the association of bacteraemia caused by extended-spectrum β-lactamase-producing Enterobacteriaceae and patient …

WC Rottier, HSM Ammerlaan… - Journal of Antimicrobial …, 2012 - academic.oup.com
Background and objectives Bacteraemia caused by Enterobacteriaceae (EB) producing
extended-spectrum β-lactamase (ESBL+) has been associated with higher mortality compared …

Adequacy of Antimicrobial Treatment and Outcome of Staphylococcus aureus Bacteremia in 9 Western European Countries

H Ammerlaan, H Seifert, S Harbarth… - Clinical infectious …, 2009 - academic.oup.com
Background. Little is known about the incidence of inadequate treatment of severe Staphylococcus
aureus infection in Europe. We aimed to evaluate the adequacy of antibiotic therapy …

[HTML][HTML] Immunogenicity and reactogenicity of SARS-CoV-2 vaccines in people living with HIV in the Netherlands: A nationwide prospective cohort study

…, LBS Gelinck, EF Schippers, HSM Ammerlaan… - PLoS …, 2022 - journals.plos.org
Background Vaccines can be less immunogenic in people living with HIV (PLWH), but for
SARS-CoV-2 vaccinations this is unknown. In this study we set out to investigate, for the …

A novel haemocytometric COVID-19 prognostic score developed and validated in an observational multicentre European hospital-based study

…, ICA Munnix, A Dofferhof, V Scharnhorst, H Ammerlaan… - Elife, 2020 - elifesciences.org
COVID-19 induces haemocytometric changes. Complete blood count changes, including new
cell activation parameters, from 982 confirmed COVID-19 adult patients from 11 European …

Predictive value of prior colonization and antibiotic use for third-generation cephalosporin-resistant enterobacteriaceae bacteremia in patients with sepsis

…, PD van der Linden, HSM Ammerlaan… - Clinical infectious …, 2015 - academic.oup.com
Background. To prevent inappropriate empiric antibiotic treatment in patients with bacteremia
caused by third-generation cephalosporin (3GC)–resistant Enterobacteriaceae (3GC-R EB)…

Eradication of carriage with methicillin-resistant Staphylococcus aureus: effectiveness of a national guideline

HSM Ammerlaan, JAJW Kluytmans… - Journal of …, 2011 - academic.oup.com
Background We evaluated the effectiveness of eradication of methicillin-resistant Staphylococcus
aureus (MRSA) carriage in the Netherlands after the introduction of a guideline in 2006…

The value of open-source clinical science in pandemic response: lessons from ISARIC

…, R Alves, M Amaral, N Amira, H Ammerlaan… - The Lancet infectious …, 2021 - thelancet.com
The International Severe Acute Respiratory and Emerging Infection Consortium (ISARIC) is
a global federation of clinical research networks that work collaboratively to prevent illness …